data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Innoviva
(NASDAQ:INVA)
$13.18
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$13.18
PreMarket: 4:01PM EDT
Day Range- - -52 Wk Range11.57 - 20.71Open / Close- / -Float / Outstanding60.4M / 69.8M
Vol / Avg.- / 601.1KMkt Cap919.7MP/E3.9850d Avg. Price12.95
Div / Yield-Payout Ratio-Total Float60.4MEPS3.81

Innoviva Stock (NASDAQ:INVA), Quotes and News Summary

Innoviva Stock (NASDAQ: INVA) stock price, news, charts, stock research, profile.

Day Range- - -52 Wk Range11.57 - 20.71Open / Close- / -Float / Outstanding60.4M / 69.8M
Vol / Avg.- / 601.1KMkt Cap919.7MP/E3.9850d Avg. Price12.95
Div / Yield-Payout Ratio-Total Float60.4MEPS3.81
Vandana Singh - Sep 19, 2022, 2:28PM
Akanksha Bakshi - Jul 13, 2022, 5:29PM
Vandana Singh - Jul 11, 2022, 8:14AM
Vandana Singh - May 23, 2022, 10:04AM
Vandana Singh - Feb 10, 2022, 6:55AM
Business Wire - 1 day ago
Business Wire - Nov 9, 2022, 4:05PM
Globe Newswire - Oct 19, 2022, 8:00AM
Business Wire - Oct 14, 2022, 4:10PM
Globe Newswire - Oct 12, 2022, 8:30AM
Business Wire - Sep 8, 2022, 7:00AM
Business Wire - Aug 22, 2022, 8:55AM
Business Wire - Jul 27, 2022, 4:05PM
Globe Newswire - Jul 14, 2022, 12:45PM
Business Wire - Jul 13, 2022, 4:32PM
Globe Newswire - Jul 13, 2022, 4:25PM
Newsfile - Jul 12, 2022, 9:37AM
PRNewswire - Jul 11, 2022, 11:44PM
Business Wire - Jul 11, 2022, 8:34PM
Business Wire - Jul 11, 2022, 9:17AM
Business Wire - Jul 11, 2022, 7:30AM
Business Wire - Jul 8, 2022, 8:35AM
PRNewswire - Jun 21, 2022, 2:55PM
PRNewswire - Jun 14, 2022, 3:57PM
PRNewswire - Jun 7, 2022, 5:30PM
Business Wire - Jun 3, 2022, 11:30AM
PRNewswire - May 30, 2022, 12:05PM
PRNewswire - May 24, 2022, 6:36PM
Globe Newswire - May 24, 2022, 4:04PM
Newsfile - May 24, 2022, 11:43AM
PRNewswire - May 23, 2022, 8:50PM
Business Wire - May 23, 2022, 2:25PM
Globe Newswire - May 23, 2022, 8:30AM
Business Wire - May 23, 2022, 8:30AM
Business Wire - Apr 27, 2022, 5:11PM
PRNewswire - Mar 31, 2022, 4:05PM
Business Wire - Mar 3, 2022, 7:45AM
Business Wire - Mar 2, 2022, 7:30AM
PRNewswire - Feb 10, 2022, 9:31AM
Business Wire - Feb 9, 2022, 4:45PM
Seeking Alpha - 1 day ago
InvestorPlace - Oct 31, 2022, 7:20PM
TipRanks - Oct 13, 2022, 12:40PM
InvestorsObserver - Oct 13, 2022, 12:19PM
InvestorsObserver - Oct 7, 2022, 1:19PM
InvestorsObserver - Oct 5, 2022, 2:20PM
InvestorsObserver - Sep 27, 2022, 3:44PM
Seeking Alpha - Sep 19, 2022, 3:40PM
InvestorsObserver - Sep 13, 2022, 3:02PM
InvestorPlace - Sep 2, 2022, 6:00AM
InvestorsObserver - Aug 19, 2022, 2:52PM
Seeking Alpha - Aug 18, 2022, 7:43AM
TipRanks - Aug 8, 2022, 12:38PM
InvestorsObserver - Jul 28, 2022, 12:12PM
Seeking Alpha - Jul 20, 2022, 1:10PM
InvestorsObserver - Jul 15, 2022, 2:47PM
TipRanks - Jul 15, 2022, 12:43PM
InvestorsObserver - Jul 14, 2022, 2:30PM
Seeking Alpha - Jul 13, 2022, 5:13PM
InvestorPlace - Jul 11, 2022, 11:15AM
Seeking Alpha - Jul 11, 2022, 7:46AM
Seeking Alpha - Jun 7, 2022, 2:58PM
Seeking Alpha - Jun 7, 2022, 2:58PM
Seeking Alpha - May 23, 2022, 8:57AM
InvestorsObserver - Apr 29, 2022, 10:39AM
InvestorsObserver - Apr 28, 2022, 11:46AM
InvestorsObserver - Apr 27, 2022, 1:55PM
TipRanks - Apr 12, 2022, 12:35PM
InvestorsObserver - Mar 14, 2022, 11:54AM
InvestorsObserver - Mar 3, 2022, 10:43AM
Seeking Alpha - Mar 3, 2022, 7:58AM
InvestorsObserver - Mar 2, 2022, 9:44AM
Seeking Alpha - Mar 2, 2022, 7:43AM
InvestorsObserver - Feb 24, 2022, 12:26PM
Seeking Alpha - Feb 21, 2022, 2:05PM
Sector: Health Care.Industry: Pharmaceuticals
Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline.
Read More

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-08
REV
Q3 2022Est.ActualSurprise
EPS2.2402.800 0.5600
REV200.480M67.257M-133.223M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Innoviva (INVA) stock?

A

You can purchase shares of Innoviva (NASDAQ: INVA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Innoviva's (INVA) competitors?

Q

What is the target price for Innoviva (INVA) stock?

A

The latest price target for Innoviva (NASDAQ: INVA) was reported by Morgan Stanley on Thursday, October 13, 2022. The analyst firm set a price target for 14.00 expecting INVA to rise to within 12 months (a possible 6.22% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Innoviva (INVA)?

A

The stock price for Innoviva (NASDAQ: INVA) is $13.18 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Innoviva (INVA) pay a dividend?

A

There are no upcoming dividends for Innoviva.

Q

When is Innoviva (NASDAQ:INVA) reporting earnings?

A

Innoviva’s Q4 earnings are confirmed for Wednesday, February 8, 2023.

Q

Is Innoviva (INVA) going to split?

A

There is no upcoming split for Innoviva.

Q

What sector and industry does Innoviva (INVA) operate in?

A

Innoviva is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.